top of page

Email:  bd@sidmexinovia.com | Phone:  +918866862020

  • Whatsapp
  • Instagram
  • Facebook
  • X
  • LinkedIn

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Zerofos 667mg Tablet

Zerofos 667mg Tablet

Manufacturer/Marketed By : ALNICHE LIFE SCIENCES PVT LTD

$0.46 $0.45

Zerofos 667mg tablet contains the active component Calcium acetate. It is a medication commonly used to manage high phosphate levels in the blood, known as hyperphosphatemia. It is primarily used...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

CALCIUM ACETATE

Active Pharmaceutical Ingredient

Zerofos 667mg Tablet

SKU ALNICHE LIFE SCIENCES PVT LTD
Precio original

0,46$

Precio de oferta

0,45$

Zerofos 667mg tablet contains the active component Calcium acetate. It is a medication commonly used to manage high phosphate levels in the blood, known as hyperphosphatemia. It is primarily used in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) undergoing dialysis. It helps to maintain better bone health and reduce the risk of bone fractures and other bone-related issues. Zerofos 667mg tablet may reduce the risk of cardiovascular problems such as heart disease and calcification of blood vessels. It can be used as an adjunct to dietary modifications, improving the ability to control phosphate levels effectively. High phosphate levels can contribute to symptoms like itching and skin irritation, which are common in individuals with kidney disease. Lowering phosphate levels with it may provide relief from these symptoms. If you experience hypersensitivity or an allergic reaction to the Zerofos 667mg tablet or any of its components, it is important to avoid this medication. Patients with severe kidney impairment or impairment of calcium metabolism should avoid this medication. Caution should be exercised in individuals with a history of kidney stones or kidney disease and those taking medications containing Calcium or magnesium. It is generally not recommended for use in children due to insufficient clinical data in pediatric populations. In older individuals, the use of this medication should be approached with caution because in older age, so many health problems present, such as they may have an increased risk of various health conditions, including impaired kidney function, cardiovascular issues, and calcium-related disorders. It is always important to consult a healthcare professional before starting this medication in old age.

Active Pharmaceutical Ingredient

CALCIUM ACETATE

Uses

• Hyperphosphatemia in CKD/ESRD
• Adjunct to dietary management in CKD/ESRD dialysis

Benefits

Zerofos 667mg tablet's therapeutic action is its ability to bind with dietary phosphate in the gastrointestinal tract. Upon ingestion, it dissociates into calcium and acetate ions. The calcium ions form insoluble complexes with phosphate ions from ingested foods, forming calcium phosphate salts that are not absorbed into the bloodstream. As a result, phosphate absorption from the diet is reduced, leading to lower phosphate levels in the blood.

Side Effects

Zerofos 667mg tablet causes some side effects like all medications, although not everyone will experience them.

Most Common Side Effects

• Upset stomach
• Constipation
• Abdominal pain
• Loss of appetite
• Itching
• Hypocalcemia

Common Side Effects

• Hypercalcemia
• Calcium-based tissue deposition
• Aluminum toxicity

How To Use

Zerofos 667mg tablet is typically administered orally, meaning it is taken by mouth as tablets or capsules. The medication is designed to be swallowed with water and should not be chewed or crushed unless specifically instructed by a healthcare provider. The oral route is the most common and effective way to use this medication to manage hyperphosphatemia in individuals with chronic kidney and end-stage renal disease.

Safety Advice

• Breast Feeding: Zerofos 667mg tablet's safety during breastfeeding is not well established. Consult a healthcare provider before using this medication while breastfeeding.
• Alcohol: It is unsafe to use alcohol with Zerofos 667mg tablet as interaction can cause certain side effects and also reduces the efficacy of this medication. If you experience dizziness or nausea, it is unsafe to take Zerofos 667mg tablet with alcohol.
• Liver: Individuals with liver disease should consult a doctor regarding using Zerofos 667mg tablet with their healthcare provider, as there may be considerations related to calcium and phosphate metabolism.
• Lungs: If you have lung conditions, it is advisable to consult your healthcare provider before using Zerofos 667mg tablet.
• Driving: If you are experiencing side effects that could affect your ability to drive or operate machinery safely, taking a Zerofos 667mg tablet while driving is unsafe.
• Pregnancy: Pregnant women should consult their healthcare provider before taking Zerofos 667mg tablet as its safety is not well studied in pregnant women.

Disclaimer

Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.

Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.

All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.

Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.

bottom of page